MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- Sector Info (pharmaceuticals)
- Indian Pharma
Indian Pharma Stocks 
Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.
Airs Tomorrow at 5pm: The Instant Income Summit
| SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
|---|---|---|---|---|
| AARTI DRUGS | 619.50 -1.08% | 617.05 -1.53% | More Info
|
|
| AJANTA PHARMA | 1,189.10 4.88% | 1,190.10 4.68% | More Info
|
|
| ALEMBIC PHARMA | 598.10 -0.90% | 597.90 -0.62% | More Info
|
|
| BIOCON | 291.35 0.31% | 291.60 0.36% | More Info
|
|
| CADILA HEALTHCARE | 267.60 -0.56% | 267.30 -0.69% | More Info
|
|
| CIPLA | 480.70 0.09% | 480.45 0.03% | More Info
|
|
| DIVIS LABORATORIES | 1,895.35 -0.43% | 1,895.35 -0.42% | More Info
|
|
| DR. REDDYS LAB | 3,059.75 0.86% | 3,060.00 0.85% | More Info
|
|
| GLENMARK PHARMA | 350.60 -2.65% | 351.15 -2.44% | More Info
|
|
| INDOCO REMEDIES | 211.00 3.28% | 210.35 2.53% | More Info
|
|
| IPCA LABS | 1,216.85 -1.37% | 1,218.15 -1.36% | More Info
|
|
| J.B.CHEMICALS | 483.80 1.83% | 484.25 1.89% | More Info
|
|
| LUPIN | 733.95 -4.22% | 733.90 -4.27% | More Info
|
|
| NATCO PHARMA | 638.40 2.27% | 638.80 2.13% | More Info
|
|
| NIFTY 50 | Not Listed | 12,234.00 -0.96% | More Info
|
|
| ORCHID PHARMA LTD | 5.25 -4.89% | 18.90 -2.83% | More Info
|
|
| PANACEA BIOTECH | 131.60 -0.75% | 131.60 -1.16% | More Info
|
|
| PIRAMAL ENTERPRISES | 1,596.20 -1.90% | 1,600.00 -1.68% | More Info
|
|
| S&P BSE SENSEX | 41,584.61 -0.86% | Not Listed | More Info
|
|
| STRIDES PHARMA SCIENCE | 388.45 0.43% | 388.00 0.45% | More Info
|
|
| SUN PHARMA | 449.20 -1.16% | 449.35 -1.15% | More Info
|
|
| TORRENT PHARMA | 2,039.00 1.61% | 2,028.50 1.10% | More Info
|
|
| WOCKHARDT | 285.00 -0.58% | 285.50 -0.37% | More Info
|
BSE prices: January 20, 2020 02:57:00 PM NSE prices: January 20, 2020 3:00:00 PM
Indian Pharma Stocks Update
The NIFTY PHARMA Index is currently trading at 8,278.5 (down 0.8%). The index is down 19.7% over the last 30 days. And over the last 1 year, it has lost 11.9%.
Within the Indian Pharma sector, the top gainers are AJANTA PHARMA (up 4.9%) and INDOCO REMEDIES (up 3.3%). On the other hand, LUPIN (down 4.2%) and GLENMARK PHARMA (down 2.7%) are among the top losers.
Meanwhile, the benchmark NIFTY 50 is at 12,234.0 (down 1.0%).
Today's Market
Sensex Falls 200 Points; TCS & HDFC Bank Top Losers(12:30 pm)
Share markets in India have erased early gains and are presently trading on a negative note. Benchmark indices rose to their respective all-time highs in early trade today.
Related Views on News
TORRENT PHARMA at All Time High; BSE HEALTHCARE Index Down 0.1% (Market Updates)
Jan 20, 2020 | Updated on Jan 20, 2020TORRENT PHARMA share price has hit an all time high at Rs 2,073 (up 2.9%). The BSE HEALTHCARE Index is down by 0.1%. Among the top gainers in the BSE HEALTHCARE Index today are TORRENT PHARMA (up 2.9%) and ABBOTT INDIA (up 0.1%). The top losers include CADILA HEALTHCARE (down 0.2%) and WOCKHARDT (down 0.3%).
TORRENT PHARMA at 52 Week High; BSE 500 Index Down 0.3 % (Market Updates)
Jan 20, 2020 | Updated on Jan 20, 2020TORRENT PHARMA share price has hit a 52-week high. It is presently trading at Rs 2,035. BSE 500 Index is down by 0.3% at 16,158. Within the BSE 500, TORRENT PHARMA (up 1.1%) and NHPC LTD (up 11.4%) are among the top gainers, while top losers are POWER FINANCE CORPORATION and INOX WIND.
DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Down 0.1% (Market Updates)
Jan 20, 2020 | Updated on Jan 20, 2020DIVIS LABORATORIES share price has hit an all time high at Rs 1,925 (up 0.7%). The BSE HEALTHCARE Index is down by 0.1%. Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (up 0.7%) and DR. REDDYS LAB (up 0.7%). The top losers include ABBOTT INDIA (down 0.3%) and ALEMBIC PHARMA (down 0.3%).
J.B.CHEMICALS at 52 Week High; BSE 500 Index Down 0.2 % (Market Updates)
Jan 20, 2020 | Updated on Jan 20, 2020J.B.CHEMICALS share price has hit a 52-week high. It is presently trading at Rs 487. BSE 500 Index is down by 0.2% at 16,158. Within the BSE 500, J.B.CHEMICALS (up 1.9%) and NHPC LTD (up 15.7%) are among the top gainers, while top losers are L&T FINANCE HOLDINGS and MANPASAND BEVERAGES.
CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)
Nov 15, 2019 | Updated on Nov 15, 2019For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.
More Views on NewsMost Popular
My Latest Stock Recommendation (Fast Profits Daily)
Jan 10, 2020The story behind my latest stock recommendation and an important announcement.
Saffron Curtain = Hindutva Rate of Growth? (The Honest Truth)
Jan 8, 2020Will the Indian economy revert to a sub-3% growth rate?
Your Safe Income Options for 2020 (Fast Profits Daily)
Jan 9, 2020What are you safest investing options in 2020 when interest rates fall.
Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)
Jan 14, 2020The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.
Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)
Jan 15, 2020These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.
MoreOUR TOP 5 IDEAS
- Free Guide on How to Profit from Sensex 100,000.
- A Simple Test to Find out If a Stock Has 100x Potential
- A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Revealed: Top 7 Stocks to Consider Buying Right Now...
S&P BSE HEALTHCARE
Jan 20, 2020 02:57 PM
S&P BSE HEALTHCARE 5-YR ANALYSIS
COMPARE COMPANY
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.